Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Veracyte: Q4 Earnings Snapshot
Veracyte: Q4 Earnings Snapshot
Associated Press Finance
Thu, February 26, 2026 at 6:37 AM GMT+9 1 min read
In this article:
VCYT
+0.08%
SOUTH SAN FRANCISCO, Calif. (AP) — SOUTH SAN FRANCISCO, Calif. (AP) — Veracyte Inc. (VCYT) on Wednesday reported fourth-quarter profit of $41.1 million.
The South San Francisco, California-based company said it had net income of 51 cents per share. Earnings, adjusted for one-time gains and costs, were 53 cents per share.
The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 41 cents per share.
The molecular diagnostic company posted revenue of $140.6 million in the period.
For the year, the company reported profit of $66.4 million, or 82 cents per share. Revenue was reported as $517.1 million.
Veracyte expects full-year revenue in the range of $570 million to $582 million.
This story was generated by Automated Insights () using data from Zacks Investment Research. Access a Zacks stock report on VCYT at
Terms and Privacy Policy
Privacy Dashboard
More Info